Modeling published in Neurology and Therapy suggests that lecanemab could delay progression to Alzheimer’s dementia by several years
STOCKHOLM, April 27, 2022 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) companion Eisai introduced at the moment that ...
